Digital Conference Handbook

Download a copy of the digital conference handbook to view the full program, abstract poster and oral listings, international and sponsored speaker biographies and delegate and speaker information.

Download long-arrow-right

Wednesday 19 February

Time Session
9:00am - 4:00pm Faculty of Radiation Oncology Lung Interest Cooperative (FROLIC) Workshop

(Dr. Louis Lao, A/Prof Gerry Hanna)

View full program. 

8:00am - 5:00pm Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) Nursing and Allied Health Workshop

(Proudly Sponsored By Roche)

Session 1: Quality In Diagnostics & Care

Session 2: Hope & Equity

Session 3: Living with thoracic cancer and beyond

Session 4: Improving nurse and patient outcomes in lung cancer

View full program. 

9:30am - 5:00pm Australasian Lung Cancer Trials Group (ALTG) Clinical Development Workshop and open SAC meeting
10:00am - 3:00pm Lung Cancer Community Forum

View full program. 

Thursday 20 February

Time Session
7:00am - 8:00am Australasian Lung Cancer Trials Group MAC Meeting

(ALTG members only)

8:00am - 9:00am Opening Ceremony
9:00am - 10:00am Keynote Presentation

• Future Directions for Research in Lung Cancer (Dr. Marina Garassino)

• Air Quality (Prof Bin Jalalundi)

10:00am - 10:30am Morning Tea and Poster Presentations
10:30am - 12:30pm Palliative Care Symposium

• Introduction; cancer patients' perspectives of palliative care (Dr. Jaclyn Yoong)

• Inpatient Palliative Care Services (Dr. Michael Chapman)

• Community Palliative Care Services (Dr. Eswaran Waran)

• Early Palliative Care (Prof David Currow)

• Palliative Care Research Update (Prof Jane Phillips)

10:30am - 12:30pm Plenary - Quality in Diagnostics and Care: ‘Leaps & Bounds’ in Lung Cancer in 2020

Chairs: A/Prof Tom John

• Science & Pathology (A/Prof Marie-Liesse Labat)

• Diagnostics (Prof. Stephen Fox)

• Medical Oncology (Targeted Therapy) (Dr. Federico Cappuzzo)

• Radiation Oncology (A/Prof Gerry Hanna)

• Surgery (A/Prof Gavin Wright)

• Allied Health (Dr Lara Edbrooke)

• Nursing ( Mary Duffy, APN Lung Cancer Nurse Specialist)

• Speaker Panel

10:30am - 12:00pm Pfizer Symposium - Lung Pathology In the Era of Targeted Therapies: ROS1 Testing in Patients with Advanced Non-Small Cell Lung Cancer

(A/Prof Nick Pavlakis and A/Prof Trishe Leong)

10:30am - 12:30pm Poster Viewing
12:30pm - 1:30pm Lunch and Poster Presentations
12:30pm - 2:00pm Roche Symposium - Non-Squamous NSCLC: Selecting The Right Treatment Regimen for Each Patient

(Dr. Federico Cappuzzo – Italy)

1:30pm - 3:00pm Basic Science Symposium: Novel insights into the biology of thoracic cancers

Chairs: A/Prof Marie-Liesse Asselin-Labat and Dr. Kate Sutherland

• Dichotomising high dimensional data: exploring immune checkpoint blockade response with bulk and single cell RNA sequencing (Dr. Melvin Chin)

• Interrogating the immune microenvironment in primary lung cancer and metastases (Dr. Clare Weeden)

• Targeting epigenetic dysregulation in SWI/SNF-deficient lung adenocarcinoma (Dr. Jason Cain)

• Exploiting cell cycle-mediators to enhance chemotherapy response in non-small cell lung cancer (Dr. Mark Adams)

• Identifying therapeutic approaches to treat KEAP1-mutant lung adenocarcinoma (Dr. Sarah Best)

• Mechanisms of immune evasion in small cell lung cancer (Dr. Marian Burr)

1:30pm - 3:30pm Oral Abstract Presentations: Screening and Early Detection

Chair: Prof Kwun Fong

• Standard Oral Presentations

1:30pm - 3:30pm Plenary - Hope & Equity: Reinventing Clinical Trials

Co-chairs A/Prof Rob Stirling and Dr. Vanessa Brunelli, Lung Cancer Research Fellow

• Real world research participation: Setting the Stage (Linnea Olsson, Consumer Advocate - by video)

• Representation of minorities in oncology clinical trials (Dr Craig Underhill)

• Debate (featuring surprise debaters!)

  o Argument: Lung cancer patients should have access to clinical trials. Relax the eligibility criteria!

  o Rebuttal: Strict criteria are crucial in clinical trials to ensure scientific purity. Do not relax the eligibility criteria!

• PROMs, PREMs and Quality: Partnering with Patients to Develop Meaningful Measures (A/Prof Rob Stirling)

• Beyond 3rd Generation: Innovation in Clinical Trials (Prof Ben Solomon)

• Speaker panel discussion: Clinical trials: “I want the future….”

1:30pm - 3:30pm Living with Thoracic Cancer and Beyond: Exercise in Lung Cancer

Chairs: Dr Lara Edbrooke and Dr Ashanya Malalasekera

• Update: Exercise Oncology Guidelines and Position Statements (Prof Rob Newton)

• Mechanisms behind the effects of exercise in lung cancer (Mr. Jin-Soo Kim)

• Prehab & Prehab Guidelines in Oncology (Prof Linda Denehy)

• Advances in evidence for exercise following surgery and for those with inoperable disease (Dr Vinicius Calvalheri)

• Models of exercise prescription and community engagement in survivorship the real-world experience (Jane Turner)

1:30pm - 3:30pm Poster Viewing
4:00pm - 6:00pm Australasian Lung Cancer Trials Group (ALTG) Clinical Trial Concepts

(all delegates welcome)

• DREAM3R: DuRvalumab (MEDI4736) with chEmotherapy as first line treAtment in advanced pleural Mesothelioma - A phase 3 Randomised trial. (Prof Anna Nowak)

• ASPIRATION: An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients. (A/Prof Nick Pavlakis)

4:00pm - 5:00pm Oral Abstracts: Epidemiology
4:00pm - 5.30pm Plenary - Living with Thoracic Cancer and Beyond: Holistic Long-term Care

Chairs: Dr. Ashanya Malalasekera

• The lived experience of long-term survivors (Consumer Advocate presentation)

• Patient experience research of unmet need: the PEEK Study (Dr Catherine Holliday)

• Models of survivorship care and long-term surveillance: What works? (Dr. Joel Rhee)

• What we can learn from Palliative Care colleagues: a positive blend of Palliative Care and Survivorship (Dr. Jaclyn Yoong)

• Voluntary Assisted Dying: what you and your patients want to know (Dr. Melissa Yang, Jacqueline Lesage, Consumer Advocate)

Followed by speaker panel discussion

6:00pm - 7:30pm Merck Sharp & Dohme Symposium - Redefining Survival Expectations For Lung Cancer Patients

(Prof. Nir Peled – Israel)

7:00pm - 07:30pm Lung Foundation Australia Welcome Cocktail Reception
7:30pm - 11:00pm Lung Foundation Australia Dinner (including Lung Cancer Research Awards)

Friday 21 February

Time Session
7:00am - 9:00am Australasian Lung Cancer Trials Group (ALTG) Strategic Planning Meeting

(ALTG members only)

7:30 am - 9:00 am Bristol Myers Squibb Symposium: What is the future of immunotherapy in NSCLC?

Speaker: Prof. Michael Boyer

• What will the lung cancer population look like in the future?

• IO in early stage NSCLC

• IO in stage III NSCLC

• Overcoming IO resistance in stage IV NSCLC

Followed by speaker panel discussion

9:00am - 10:00am Keynote presentation

• Working together: The Power of a Multi-Disciplinary Approach in Lung Cancer Treatment & Care (Prof. Angela Tod - UK)

• E-cigarettes: good intentions gone awry? The Harmful Consequences (Prof. Martin Phillips)

10:00am - 10:30am Morning Tea, Poster Viewing and Presentations
10:30am - 12:30pm Oral Abstract Presentations: Medical Oncology

• Rapid Fire Group Presentations

• Standard Oral Presentations

10:30am - 12:30pm Oral Abstract Presentations: Are We Delivering Best Practice Treatment?

Chair: A/Prof Rob Stirling

• Standard Oral Presentations

10:30am - 12:30pm Symposium: Borderline Inoperable Disease

Chair: Mr Stephen Barnett and A/Prof Gerry Hanna

(tracks: radiology / radiation oncology / surgery)

• Optimal surgical management of stage 1 disease (Mr Julian Gooi)

• What role for non-surgical treatment in stage 1 disease? (Dr Susan Harden )

Followed by speaker panel discussion

• Surgery in stage 3 disease: is there a role? (Prof Siven Seevanayagam)

• Should all stage 3 disease be treated with radiation therapy treatments? (Dr Fiona Hegi-Johnson)

Followed by speaker panel discussion

10:30am - 12:30pm Poster Viewing
10.30am - 12:30pm Plenary - Quality in Diagnostics & Care: Lung Cancer Screening in Australia

Chairs: Prof Kwun Fong and Prof Fraser Brims

• Setting the scene: The Cancer Australia Enquiry (Dr. Vivienne Milch, Cancer Australia)

• Screening and smoking cessation (Dr. Henry Marshall)

• Screening and comorbidities (A/Prof Paul Mitchell)

• Considerations in computer-aided detection, radiomics and artificial intelligence (AI) (Dr. Brendan Adler)

• Maximising uptake: the hard to reach and underserved (Dr. Niranjan Karanth)

• Looking to international efforts to drive local implementation (Prof. Nir Peled)

Followed by speaker panel discussion

12:30pm - 2:00pm AstraZeneca Symposium - Putting evidence into practice in locally advanced and metastatic NSCLC

(Dr. Marina Garassino - Milan)

12:30pm - 1:30pm Lunch and Poster Presentations
1:30pm - 3:00pm Oral Abstract Presentations: Basic Science

Chair: Dr Tracy Leong

• Standard Oral Presentations

1:30pm - 3:00pm Oral Abstract Presentations: Data-driven quality and care

• Standard Oral Presentations

1:30pm - 3:30pm Plenary - Hope & Equity: Toward 2030 – Achieving Hope and Equity Over The Next Decade

Chairs: A/Prof Rob Stirling and Mary Duffy, APN, Lung Cancer Nurse Consultant.

• Engaging The Patient Voice (Dr. Lisa Briggs, Consumer Advocate)

• Nurse Led Models (Prof. Angela Tod – UK)

• Equity: Do We Have It? (Prof. David Ball)

• Using Health Systems Data to Drive And Monitor Change

• Learnings From The Victorian Lung Cancer Registry (A/Prof Rob Stirling)

Followed by speaker discussion panel: Blue skies; where do we want to be in 2030 and how will we get there?

1:30pm - 3:30pm Mesothelioma Proudly Sponsored by Maurice Blackburn

• Epidemiology (Prof Fraser Brims)

• Genomics and Mesothelioma (Dr. Nicola Waddell)

• Surgical Approaches To Mesothelioma (A/ Prof Gavin Wright)

• Advances In Systemic Therapy (Prof Ken O’Byrne)

• Novel Targets For Treatment (Prof Anna Nowak)

• What Role For Radiation Therapy In Mesothelioma (A/Prof Gerry Hanna)

Followed by speaker panel discussion: Are we ‘Radical’ enough in our treatment approaches to mesothelioma?”

4:00pm - 5:00pm Poster Removal
3:30pm - 4:30pm Abstract & Poster Awards

Closing Ceremony

4:30pm- 4:45pm Afternoon Tea

Program at a Glance

The ALCC program is aligned to the recommendations of Making a Lung Cancer a Fair Fight: A BluePrint for Reform report and is presented in three core streams:

  • Quality in Diagnostics and Care
  • Living with Thoracic Cancer and Beyond
  • Hope and Equity

Registration is required for sponsor symposiums and workshops (FROLIC; ANZ-LCNF; ALTG) and can be added to your single-day or full conference registration.

Health Professionals can earn Continuing Professional Development (CPD) points from the ALCC progam:
  • Nurses are eligible to claim 1 CPD hour with the Australian College of Nursing (ACN) and the Australian Primary Health Care Nurses Association (APNA) for each hour of active learning attended .
  • General Practitioners are eligible to claim 2 CPD points with the Royal Australian College of General Practitioners (RACGP) for each hour of active learning attended .
Download Program at a Glance long-arrow-right

Endorsed by

In collaboration with

Proudly sponsored by